reports
BIOHIT GROUP HALF YEAR FINANCIAL REPORT 2019
BIOHIT GROUP HALF YEAR FINANCIAL REPORT 2019 Biohit Oyj Half Year Financial Report 14 August 2019 at 9:30 am local time (EET) SUMMARY January-June 2019 Net sales EUR 5.0 million (EUR 4.9 million) Net sales grew by 1% compared to H1/2018Operative EBITDA EUR +0.4 million (EUR -0.1 million)*Cash at the end of the period EUR 1.3 million (EUR 1.3 million)Net sales from international operations 95.5% (97.2%) of total net salesEquity ratio 85.9% (89.4%)** * Biohit Group implemented the IFRS 16 Leases -standard effective from 1 January 2019. This impacts on Operative EBITDA +0.1 million...
Two clinical trials with Acetium® capsule for prevention of migraine-...
Two clinical trials with Acetium® capsule for prevention of migraine-type headache have been concluded Biohit Oyj Stock Exchange Release August 9th 2019 at 15.30 pm local time (EET) In 2014, Biohit Oyj initiated two clinical trials for prevention of migraine-type headache attacks, testing the efficacy of Acetium® capsule. Because of a slow patient enrollment, the trial was subsequently extended to two additional clinical centers abroad. Despite this extension, the originally planned cohort size was not completely reached. In the whole series, Acetium® failed to show an efficacy st...
Biohit Oyj B-shares Subscribed with Stock Options I 2013
Biohit Oyj B-shares Subscribed with Stock Options I 2013 Biohit Oyj Stock Exchange Release June 12, 2019 at 13.15 a.m. (EEST) A total number of 88,552 new Biohit Oyj B-shares have been subscribed for with stock options I 2013 between 12 February 2019 and 31 May 2019. These shares have been entered into the Trade Register on June 12, 2019, as of which date the new shares will establish equal shareholder rights with the company's existing B-shares. Public trading begins on NASDAQ Helsinki as of June 13, 2019 together with the existing B-shares. The share subscription price was EUR 2.2766 p...
Biohit Plc - Managers' transactions - Söderström
Biohit Plc - Managers' transactions - Söderström Person subject to the notification requirementName: Söderström, DanielaPosition: Other senior managerIssuer: Biohit PlcLEI: 74370089ATTSNBXJVT29 Notification type: INITIAL NOTIFICATIONReference number: 74370089ATTSNBXJVT29_20190603065401_4 Transaction date: 2019-05-29Instrument type: SHAREISIN: FI0009005482Nature of the transaction: SUBSCRIPTION(X) Linked to stock option programme Transaction details(1): Volume: 25 000 Unit price: 2.2766 EUR Aggregated transactions(1): Volume: 25 000 Volume weighted average price: 2.2766 ...
Notice of Biohit Oyj’s Annual General Meeting
Notice of Biohit Oyj’s Annual General Meeting Notice of Biohit Oyj’s Annual General Meeting Biohit Oyj Stock Exchange Release March 29, 2019 at 9:30 am local time (EEST) Biohit Oyj shareholders are invited to attend the company’s Annual General Meeting to be held on Wednesday, April 24, 2019 starting at 5:00 pm at hotel Crowne Plaza. The address is Mannerheimintie 50, 00260 Helsinki. The reception of shareholders registered for the meeting and the distribution of voting slips will commence at 4:00 pm. Coffee will be served. A. Matters on the agenda of the Annual General M...
Publication of Biohit Oyj Annual Report 2018
Publication of Biohit Oyj Annual Report 2018 Biohit Oyj Annual Financial Report March 29, 2018 at 9:30 am local time (EET) Biohit Oyj’s Annual Report 2018 is published today in PDF format. The annual report contains financial statements for 2018, the Report of the Board of Directors and Corporate Governance Statements. Annual report is published in Finnish and English, and it can be read and downloaded from Biohit company website . Additional information: CEO Semi Korpela, Biohit Oyj tel. 861 Biohit in brief Biohit ...
Biohit Oyj B-shares Subscribed with Stock Options I 2013
Biohit Oyj B-shares Subscribed with Stock Options I 2013 Biohit Oyj Stock Exchange Release February 27, 2019 at 13:30 (EEST) A total number of 5,000 new Biohit Oyj B-shares have been subscribed for with stock options I 2013 between 4 December 2018 and 11 February 2019. These shares have been entered into the Trade Register on February 27, 2019, as of which date the new shares will establish equal shareholder rights with the company's existing B-shares. Public trading begins on NASDAQ Helsinki as of February 28, 2019 together with the existing B-shares. The share subscription price was EU...
BIOHIT GROUP FINANCIAL STATEMENT RELEASE 2018
BIOHIT GROUP FINANCIAL STATEMENT RELEASE 2018 Biohit Oyj Financial Statement Release, 20 February 2019 at 9:30 am local time (EET) SUMMARY January-December 2018 Net sales EUR 9.9 million (EUR 9.0 million)Net sales grew by 10.6% compared to 2017Operative EBITDA EUR -0.1 million (EUR -0.4 million)Cash at the end of the period EUR 1.4 million (EUR 1.3 million)Net sales from international operations 95.6% (95.7%) of total net salesEquity ratio 89.2% (91.3%) July-December 2018 Net sales EUR 5.0 million (EUR 4.9 million)Net sales grew by 2.0% compared to H2/2017Operative...
Biohit Oyj: Managers' Transactions
Biohit Oyj: Managers' Transactions BIOHIT Oyj MANAGERS’ TRANSACTIONS 11 FEBRUARY 2019 05.45 P.M. Biohit Oyj: Managers' Transactions Biohit Plc - Managers' transactions - Söderström ____________________________________________ Person subject to the notification requirement Name: Söderström, Daniela Position: Other senior manager Issuer: Biohit Plc LEI: 74370089ATTSNBXJVT29 Notification type: INITIAL NOTIFICATION Reference number: 74370089ATTSNBXJVT29_20190211164318_4 ____________________________________________ Transaction ...
Business Development Director Lea Paloheimo will retire from Biohit Oy...
Business Development Director Lea Paloheimo will retire from Biohit Oyj Biohit Oyj 31.01.2019 at 12:00 local time (EST) Biohit’s management team member Business Development Director Lea Paloheimo will retire as planned 31st of January 2019. Lea Paloheimo has been employed by Biohit since 2001. ”I would like to thank Lea for the excellent work during these years at Biohit in multiple different roles”, says Semi Korpela, President and CEO of Biohit. Additional information: CEO Semi Korpela, Biohit Oyj tel. Biohit Oyj in brief Biohit Oyj is a globally operating Finnish biot...
Chief Medical Director Kari Syrjänen will retire from Biohit Oyj
Chief Medical Director Kari Syrjänen will retire from Biohit Oyj Biohit Oyj 31.12.2018 12:00 Biohit’s management team member Chief Medical Director Kari Syrjänen will retire as planned 31st of December 2018. Kari Syrjänen has been employed by Biohit since 2013. ”I would like to thank Kari for the excellent work during these years”, says Semi Korpela, President and CEO of Biohit. Additional information: CEO Semi Korpela, Biohit Oyj tel. Biohit Oyj in brief Biohit Oyj is a globally operating Finnish bio...
Biohit Oyj’s Financial Reporting and Annual General Meeting in 2019
Biohit Oyj’s Financial Reporting and Annual General Meeting in 2019 Biohit Oyj Financial calendar, November 30, 2018 at 02:45 pm local time (EET) Biohit Oyj will release its financial statements for 2018 on Wednesday 20th of February 2019 at 9:30 am. The Annual Report, which contains the Financial Statements for 2018 and the Report of the Board of Directors, will be published approximately during week 13. Biohit Oyj’s Annual General Meeting has been planned for Wednesday 24th of April 2019 at 5:00 pm. The Board of Directors will call the General Meeting at a later date. Half year fi...
Biohit Oyj B-shares Subscribed with Stock Options I 2013
Biohit Oyj B-shares Subscribed with Stock Options I 2013 Biohit Oyj Stock Exchange Release November 5, 2018 at 09.30 a.m. (EEST) A total number of 52,709 new Biohit Oyj B-shares have been subscribed for with stock options I 2013 between 5 June 2018 and 8 September 2018. These shares have been entered into the Trade Register on November 5, 2018, as of which date the new shares will establish equal shareholder rights with the company's existing B-shares. Public trading begins on NASDAQ Helsinki as of November 6, 2018 together with the existing B-shares. The share subscripti...
Stina Syrjänen resigns from Biohit Oyj’s Board of Directors
Stina Syrjänen resigns from Biohit Oyj’s Board of Directors Biohit Oyj 16.10.2018 12:20 local time Stina Syrjänen resigns from Biohit Oyj’s Board of Directors Stina Syrjänen has notified Biohit Oyj that she will resign from the company’s Board of Directors. The resignation is effective immediately. The Board of Directors of Biohit Oyj will continue to operate with five members as a new member was elected at the Extraordinary Shareholders' Meeting on the 16th of August 2018. Additional information: CEO Semi Korpela, Biohit Oyj tel. ...
The results of the migraine study will be delayed from the previousl...
The results of the migraine study will be delayed from the previously reported schedule Biohit Oyj Stock Exchange Release 07.09.2018 at 15:00 local time (EET) The results of the migraine study will be delayed from the autumn 2018 which was reported in Biohit’s Half Year Financial Report (H1 2018). In Estonia, unexpected problems have been encountered in finding eligible patients for the study. Due to these challenges, the final results will not be available until the first reporting period of 2019. Additional information: CEO Semi Korpela, Biohit Oyj ...
Biohit Oyj: Managers' Transactions
Biohit Oyj: Managers' Transactions BIOHIT OYJ MANAGERS’ TRANSACTIONS 28 AUGUST 2018 Biohit Oyj: Managers' Transactions Person subject to the notification requirement Name: Semi Korpela Position: Chief Executive Officer Issuer: Biohit Oyj LEI: 74370089ATTSNBXJVT29 __________________________________________________ Notification type: INITIAL NOTIFICATION Reference number: ...
Biohit Oyj: Managers' Transactions
Biohit Oyj: Managers' Transactions BIOHIT OYJ MANAGERS’ TRANSACTIONS 27 AUGUST 2018 Biohit Oyj: Managers' Transactions Person subject to the notification requirement Name: Semi Korpela Position: Chief Executive Officer Issuer: Biohit Oyj LEI: 74370089ATTSNBXJVT29 Notification type: INITIAL NOTIFICATION Reference number: 74370089ATTSNBXJVT29_20180827154546_2 Transaction da...
Biohit Oyj: Managers' Transactions
Biohit Oyj: Managers' Transactions BIOHIT OYJ MANAGERS’ TRANSACTIONS 24 AUGUST 2018 Biohit Oyj: Managers' Transactions Person subject to the notification requirement Name: Ilari Patrakka Position: Other Senior Management Issuer: Biohit Oyj LEI: 74370089ATTSNBXJVT29__________________________________________________ Notification type: INITIAL NOTIFICATION Reference number: 74370089AT...
Amendment: Biohit Oyj Managers' Transactions
Amendment: Biohit Oyj Managers' Transactions BIOHIT OYJ AMENDMENT: MANAGERS’ TRANSACTIONS 27 AUGUST 2018 At 13.00 local time (EET) Biohit Oyj: Managers' Transactions Person subject to the notification requirement Name: Ilari Patrakka Position: Other Senior Management Issuer: Biohit Oyj LEI: 74370089ATTSNBXJVT29__________________________________________________ Notification type: AMENDMENT Refer...
Biohit Oyj: Managers' Transactions
Biohit Oyj: Managers' Transactions BIOHIT OYJ MANAGERS’ TRANSACTIONS 24 AUGUST 2018 At 14.30 local time (EET) Biohit Oyj: Managers' Transactions Person subject to the notification requirementName: Ilari PatrakkaPosition: Other Senior Management Issuer: Biohit OyjLEI: 74370089ATTSNBXJVT29 __________________________________________________ Notification type: INITIAL NOTIFICATIONReference number: 7437...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.